A Study Evaluating Bemarituzumab in Solid Tumors With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression

ABSTRACT: The primary objectives of this study are to observe the safety and tolerability of bemarituzumab and to evaluate preliminary antitumor activity.

DISEASE(S): Colorectal Adenocarcinoma,Intrahepatic Cholangiocarcinoma,Endometrial Adenocarcinoma,Cervical Carcinoma Recurrent,Cervical Carcinoma,Breast Cancer,Neoplasms,Squamous Cell Carcinoma Of Head And Neck,A Phase 1b/2, Multicenter, Open-label Basket Study Evaluating The Safety And Efficacy Of Bemarituzumab Monotherapy In Solid Tumors With Fgfr2b Overexpression,Ovarian Carcinoma,Ductal Adenocarcinoma Of Pancreas,Solid Tumors,Esophageal Squamous Cell Carcinoma

PROVIDER: 2718563 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR